期刊
DRUG DELIVERY AND TRANSLATIONAL RESEARCH
卷 10, 期 5, 页码 1442-1458出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s13346-020-00732-5
关键词
Cilnidipine; PLGA; Polymeric nanoparticles; Plackett-Burman design; Rotatable central composite design; Pharmacokinetic study
资金
- Department of Science and Technology
Cilnidipine (CND) is known to have low oral bioavailability due to its poor aqueous solubility, low dissolution rate, and high gut wall metabolism. In the present study, CND-loaded PLGA nanoparticles (CND-PLGA-NPs) were prepared with two different grades of PLGA (50:50 and 75:25) by design of experiment. Critical factors affecting particle size and entrapment efficiency (EE%) were assessed by mixed design approach, comprising of Plackett-Burman design followed by rotatable central composite design. Particle size, PDI, zeta potential, and EE% of optimized formulations of CND-PLGA(50:50)-NPs and CND-PLGA(75:25)-NPs were 211.6 +/- 1.8 nm, 0.21 +/- 0.05, - 15.1 +/- 1.6 mV, and 85.9 +/- 1.5% and 243.5 +/- 2.4 nm, 0.23 +/- 0.06, -19.6 +/- 1.3 mV, and 92.0 +/- 1.2% respectively. No significant changes were observed in physical stability of NPs when stored at 25 degrees C/60% RH over a period of 3 months. Pharmacokinetic studies revealed that F-abs of CND-PLGA(50:50)-NPs (1.15) and CND-PLGA(75:25)-NPs (2.23) were significantly higher than the free CND (0.26). The C-max and AUC(0-infinity) of CND-PLGA(50:50)-NPs (787.42 +/- 27.38 ng/mL and 9339.37 +/- 252.38 ng/ml x h) and CND-PLGA(75:25)-NPs (803.49 +/- 19.63 ng/mL and 18,153.34 +/- 543.05 ng/ml x h) were significantly higher (p < 0.0001) compared with free CND (367.69 +/- 47.22 ng/mL and 2107.95 +/- 136.40 ng/ml x h). MRTOral of CND-PLGA(50:50)-NPs (33.36 +/- 0.48 h) and CND-PLGA(75:25)-NPs (48.37 +/- 0.61 h) were significantly higher (p < 0.0001) compared with free CND (4.69 +/- 0.58 h). CND-PLGA-NPs can provide higher and sustained plasma drug levels of CND and be effective in antihypertensive therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据